Test to Match Cancer Drugs, Imperial College London and Collaborator Study Reveals
Daily Mail UK -- A new hi-tech test could be used to predict which breast cancer patients would benefit from anti-hormonal drugs and which would do better on other treatments, research revealed today. Treatments such as tamoxifen and anastrozole work by interfering with the female hormone oestrogen, which is known to be the most important factor in the development of breast cancer.